These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23196756)

  • 1. Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.
    Perez-Medina T; Pereira A; Mucientes J; García-Espantaleón M; Jiménez JS; Calles L; Rodríguez B; Iglesias E
    Int J Gynecol Cancer; 2013 Jan; 23(1):170-5. PubMed ID: 23196756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of para-aortic surgical staging compared to
    De Cuypere M; Lovinfosse P; Goffin F; Gennigens C; Rovira R; Duch J; Fastrez M; Gebhart G; Squifflet JL; Luyckx M; Charaf G; Crener K; Buxant F; Bucella D; Jouret M; Hustinx R; Kridelka F
    Eur J Surg Oncol; 2020 May; 46(5):883-887. PubMed ID: 31784203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
    Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
    Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
    Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
    Azaïs H; Ghesquière L; Petitnicolas C; Borghesi Y; Tresch-Bruneel E; Cordoba A; Narducci F; Bresson L; Leblanc E
    Gynecol Oncol; 2017 Nov; 147(2):340-344. PubMed ID: 28919265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
    Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
    Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Leray H; Gabiache E; Courbon F; Brenot-Rossi I; Colineaux H; Lepage B; Lambaudie E; Martinez A; Voglimacci M; Weyl A; Deslandres M; Ducassou A; Motton S; Vaysse C; Chantalat E
    J Nucl Med; 2020 Oct; 61(10):1442-1447. PubMed ID: 32034109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy.
    Chou HH; Chang TC; Yen TC; Ng KK; Hsueh S; Ma SY; Chang CJ; Huang HJ; Chao A; Wu TI; Jung SM; Wu YC; Lin CT; Huang KG; Lai CH
    J Clin Oncol; 2006 Jan; 24(1):123-8. PubMed ID: 16382121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Adam JA; van Diepen PR; Mom CH; Stoker J; van Eck-Smit BLF; Bipat S
    Gynecol Oncol; 2020 Nov; 159(2):588-596. PubMed ID: 32921477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Systematic Infrarenal Para-aortic Dissection Be the Rule in the Pretherapeutic Staging of Primary or Recurrent Locally Advanced Cervix Cancer Patients With a Negative Preoperative Para-aortic PET Imaging?
    Leblanc E; Katdare N; Narducci F; Bresson L; Gouy S; Morice P; Ferron G; Querleu D; Martinez A
    Int J Gynecol Cancer; 2016 Jan; 26(1):169-75. PubMed ID: 26569062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
    Wright JD; Dehdashti F; Herzog TJ; Mutch DG; Huettner PC; Rader JS; Gibb RK; Powell MA; Gao F; Siegel BA; Grigsby PW
    Cancer; 2005 Dec; 104(11):2484-91. PubMed ID: 16270319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH; Kim WT; Bae JS; Ki YK; Park D; Suh DS; Kim KH; Lee JH; Lee JY; Jeon HS; Nam JH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1274-80. PubMed ID: 27465890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings.
    Yildirim Y; Sehirali S; Avci ME; Yilmaz C; Ertopcu K; Tinar S; Duman Y; Sayhan S
    Gynecol Oncol; 2008 Jan; 108(1):154-9. PubMed ID: 17945337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.
    Lin SY; Tsai CS; Chang YC; Ng KK; Chang TC; Kao WH; Lai CH; Hong JH
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):577-85. PubMed ID: 25936817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.
    Rose PG; Adler LP; Rodriguez M; Faulhaber PF; Abdul-Karim FW; Miraldi F
    J Clin Oncol; 1999 Jan; 17(1):41-5. PubMed ID: 10458216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
    Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
    Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.